Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

CSBR

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Champions Oncology, Inc.

Yes. JPMorgan Chase holds 11 shares of CSBR (Champions Oncology), worth $71, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. JPMorgan Chase has held CSBR in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$71

Current Shares

11

Total Value Change

+$17

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
11
0.0%
$710.0%$6.16
0
2026-Q1
Unchanged
11
0.0%
$640.0%$5.75
0
2025-Q4
Unchanged
11
0.0%
$760.0%$6.91
0
2025-Q3
Unchanged
11
0.0%
$710.0%$6.48
0
2025-Q2
Unchanged
11
0.0%
$810.0%$7.37
0
2025-Q1
Unchanged
11
0.0%
$950.0%$8.68
0
2024-Q4
Unchanged
11
0.0%
$940.0%$8.57
0
2024-Q3
First report
11
-
$540.0%$4.87
0

Other major holders of CSBR: Vanguard Group Inc., Renaissance Technologies LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used